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Cutaneous wound healing is a well-coordinated process that includes inflammation, proliferation, and
differentiation. Activator protein 1 (AP-1) subunits have been implicated in the regulation of genes important for
these processes and have been shown to be involved in wound healing. However, investigation of human
healing and non-healing wounds in vivo and ex vivo, and the comparative analysis of several members of the
Jun and Fos families are still missing. Here, we show that normal human epidermal wound healing is biphasic. In
the first phase all AP-1 subunits investigated, that is c-Jun, Jun B, Jun D, c-Fos, and Fos B are absent from the
nuclei at the wound margins/leading edges. This downregulation coincides with that of the gap junction protein
connexin 43. Later on, c-Jun, Jun B, Jun D, and c-Fos reappear in the nuclei of the leading edges in a time-
dependent manner. In non-healing wounds, a more intensive staining of keratinocytes at the wound margins is
often observed. Our findings suggest that coordinated down- and upregulation of the various AP-1 subunits in
the course of epidermal wound healing is important for its undisturbed progress, putatively by influencing
inflammation and cell–cell communication.
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INTRODUCTION
Wound healing is a complex process that aims the
reconstruction of damaged tissue. It consists of three main
phases: inflammation, tissue formation, and tissue remodel-
ing. The inflammation phase starts immediately after wound-
ing and is dominated by release of cytokines and growth
factors, influx of neutrophils and macrophages in the
wounded area, and creation of a preliminary matrix. The
second phase, that is reepithelialization and granulation
tissue formation, starts within hours after injury and lasts for
several days. Finally, extracellular matrix is reorganized and
retracted in the phase of tissue remodeling which lasts for
several weeks. Especially in the phase of tissue formation
keratinocytes have to perform several changes, such as
dedifferentiation, proliferation, migration, and differentiation.
Several reports suggest that the transcription factor
activator protein 1 (AP-1) plays an important role in
cutaneous wound healing (for reviews see Angel et al.,
2001; Yates and Rayner, 2002; Florin et al., 2004, 2006). AP-
1 comprises several subunits that belong mainly to the Jun (c-
Jun, Jun B, and Jun D), and Fos (c-Fos, Fos B, Fra-1, and Fra-2)
families (for review see Shaulian and Karin, 2001). AP-1
subunits have been demonstrated to be differentially ex-
pressed in human skin (Welter and Eckert, 1995; Angel et al.,
2001; Mehic et al., 2005; Zenz et al., 2005). Expression
of AP-1 subunits is influenced – via MAP kinases – by various
cytokines involved in wound healing, for example epidermal
growth factor, transforming growth factor b, and ILs (for
review see Angel et al., 2001). On the other hand, several
proteins involved in cell proliferation, migration, and
differentiation harbor AP-1-binding sites, for example
keratins and metallomatrixproteinases (for reviews see Angel
et al., 2001; Yates and Rayner, 2002; Florin et al., 2004,
2006).
Transgentic mice that are conditionally deleted for c-Jun in
the epidermis show impaired wound healing due to altered
organization and migration of the leading edge during
reepithelialization (Li et al., 2003). Scratch assays with
epidermal keratinocytes demonstrate an increased phosphor-
ylation of c-Jun and ATF1 (Turchi et al., 2002). Keratinocytes
lacking c-Jun are unable to migrate or elongate properly at
the border of scratch assays (Li et al., 2003). Mice lacking Jun
B in the skin show enhanced epidermal hyperproliferation,
disturbed differentiation, and prolonged inflammation after
wounding. Moreover, tissue remodeling was delayed (Florin
et al., 2006). Gangnuss et al. (2004) showed an induction of
c-Fos and c-Jun in rodent fetal skin explants after wounding.
In interleukin-6-deficient mice, which also showed delayed
cutaneous wound healing, a decreased AP-1 activation was
found 16 hours after wounding (Gallucci et al., 2000).
Deletion of AP-1 subunits in mouse fibroblasts, co-cultured
with normal human keratinocytes has great effect on the
developing epithelial structure. C-Jun/ fibroblasts lead to a
hypoproliferation of the co-cultured keratinocytes, whereas
in co-cultures with Jun B/ fibroblasts hyperproliferative
epithelia were observed (Szabowski et al., 2000).
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As most experiments were performed in rodent skin or in
human mono- or co-cultures, it was of interest to analyse AP-
1 expression in a complex human system. Therefore, we
investigated epidermal wound healing in our established
human ex vivo wound-healing model (WHM) (Moll et al.,
1998, 1999; Brandner et al., 2002, 2004) and in in vivo
wounds of human volunteers. In addition, most investigations
concentrate on one or two AP-1 subunits. As it is known that
all subunits might act separately but coordinated, we
investigated several members of the Jun and Fos families.
Because the downregulation of the gap junction protein
connexin 43 (Cx43) at the wound margins is important for
normal wound healing (Kretz et al., 2003; Qiu et al., 2003;
Brandner et al., 2004) and there are binding sites for AP-1 in
the promoter region of Cx43 (Echetebu et al., 1999), we
compared the expression of AP-1 subunits and Cx43 at early
time points. To elucidate fundamental differences between
normal and impaired wound healing, we investigated chronic
wounds in parallel.
RESULTS
AP-1 in normal human interfollicular epidermis
Epidermal localization of the members of the Jun family was
restricted to the nuclei. Staining for c-Jun increased from
stratum basale (faint) to stratum granulosum (strong), whereas
Jun B and Jun D staining were uniform in all layers (Figure 1a,
c and e). C-Fos staining was also found in all nuclei (Figure
1b), whereas staining of Fos B was restricted to the cytoplasm
with a more intensive staining in suprabasal layers compared
to the basal cell layer (Figure 1g).
Human epidermal wound healing
We investigated several areas of the WHMs, that is the
keratinocytes at the wound margins, behind the wound
margins, of the regenerating epidermis, and of the leading
edges (Figure 2). To analyse the influence of culture
conditions on synthesis and localization of AP-1 subunits,
we also investigated cells distant from the wound margins
that should show the same staining pattern as cells in normal
epidermis. To evaluate further our WHM, we investigated the
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Figure 1. Localization of proteins of the Jun and Fos families in normal skin. Immunofluorescence microscopy of vertical sections of healthy human skin
demonstrating the localization of (a) c-Jun, (b) c-Fos, (c) Jun B , (e) Jun D , and (g) Fos B . (d, f, and h) Peptide-blocked controls of (d) Jun B, (f) Jun D, and (h) Fos B
stainings are shown. Bar¼ 50 mm.
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Figure 2. Schematic drawing of a WHM indicating the areas of investigation
described in the text. (a) Distant from the wound, (b) behind the wound
margin, (c) at the wound margin, (d) regenerating epidermis, and (e) leading
edge.
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localization of AP-1 subunits during human in vivo wound
healing 2 and 7 hours after wounding.
c-Jun. Two hours after wounding c-Jun staining was absent
from the nuclei of keratinocytes localized at the wound
margins, whereas cells just behind the wound margins
showed strong nuclear staining in all epithelial layers (Figure
3a and d). At 18, 24 hours, 2, and 3 days after wounding, cells
of the regenerating epidermis were stained more intensely
than cells at the wound margins both in the nuclei and in the
cytoplasm. Cells at the leading edges were stained notably
intense (Figure 3b and e for 18 hours). Cells behind the
wound margins were normally stained. Seven hours after
wounding the situation was in one out of three models as
found for 2 hours, in two out of three as found for 18 hours
(data not shown). In completely regenerated epidermis (5
days), all the nuclei were stained (Figure 3c). There was no
difference in staining between cells distant from the wound
margins and cells in normal epidermis at any time point (data
not shown). In in vivo experiments, the loss of c-Jun staining
at the wound margins 2 and 7 hours after wounding was
confirmed (Figure 6a and b).
Jun B. Comparable to c-Jun, nuclear staining of Jun B
vanished from the keratinocytes at the wound margins at the
beginning of wound healing (2 and 7 hours). Cytoplasmic
staining increased in these cells (Figure 3f and i). Eighteen
hours after wounding, nuclei of the regenerating epidermis
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Figure 3. Localization of c-Jun, Jun B, and Jun D in the course of wound healing. (a–e) Immunofluorescence localization of c-Jun (red), (f–j) Jun B (red), and (k–o)
Jun D (red) in vertical sections of frozen samples of human WHM (a, d, f, i, k, and n) 2 hours, (b and e) 18 hours, (g, j, l, and o) 24 hours, and (c, h, and m) 5 days
after wounding. 40,6-diamidino-2-phenylindole-stained nuclei (blue). (d) Is a higher magnification of (a), (e) of (b), (i) of (f), (j) of (g), (n) of (k), and (o) of (l) The
white line in (a) denotes the outline of the epidermis. Bar¼50 mm.
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were positive except for those of the cells at the leading edges
(data not shown). The cytoplasm was slightly weaker stained.
Twenty-four hours after wounding in three out of four
models, a very strong staining was observed in the nuclei of
the leading edges, whereas the cytoplasm was barely stained
(Figure 3g and j). One model showed a completely negative
leading edge with an intensive nuclear staining of the
epidermis behind (data not shown). In the further course of
wound healing (2 and 3 days), the nuclei of the leading edges
remained strongly positive in most models (7/10), whereas in
some models these nuclei were still negative (3/10). All other
areas of the WHM were normally stained at all time points. In
completely regenerated epidermis, all the nuclei were stained
(Figure 3f). In vivo wound healing was identical concerning
the loss of nuclear staining. The increase of cytoplasmic
staining at 2 and 7 hours was not observed (Figure 6c and d).
Jun D. Nuclear staining of Jun D decreased, cytoplasmic
staining increased at the wound margins 2 hours after
wounding, comparable to Jun B, but only very few
keratinocytes were negative (Figure 3k and n). Seven hours
after wounding, nuclear staining was still absent at the wound
margins, whereas the cytoplasmic staining persisted (data not
shown). Eighteen hours after wounding, nuclear staining at
the leading edge was absent in four out of five models,
whereas cytoplasmic staining was persisting (2/5) or decreas-
ing (3/5). During further reepithelialization (24 hours, 2, and
3 days), nuclear staining at the leading edges increased and
cytoplasmic staining was still detectable (Figure 3l and o for
24 hours). Nuclei in the regenerating epidermis were positive.
In regenerated epidermis, nuclear staining was slightly fainter
than at, near, and distant from the wound and cytoplasmic
staining was still present (Figure 3m). In vivo wound healing
was comparable to the WHM concerning the nuclei. Again,
cytoplasmic staining was negative (Figure 6e and f).
c-Fos. Two hours after wounding most nuclei of keratinocytes
located directly at the wound margins were completely
negative (Figure 4a and d), nuclei of cells behind the wound
margins were stained more intense. The nuclear staining
returned 7 hours after wounding in two out of three models
(data not shown). After 18, 24 hours, 2, and 3 days, nuclei
were positive in all areas of the WHM with apparently no
grading except for a stronger staining of the nuclei at the
leading edges in some models (4/19; Figure 4b and e, for
24 hours). In completely regenerated epidermis, nuclei were
uniformly stained (Figure 4c). In in vivo reepithelialization
nuclei at the wound margins were negative 2 and 7 hours
after wounding, cells behind the wound margins were more
intensely stained, comparable to the results found with the
WHM (Figure 6g and h).
In two out of five models at 2 days, one out of five models
at 3 days, and in all models at 5 days, cytoplasmic staining
intensity of c-Fos was slightly increased in all cells (data not
shown). Moreover, there was a slight decrease in nuclear
staining at 18 and 24 hours and a more pronounced decrease
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Figure 4. Localization of c-Fos and Fos B in the course of wound healing. Immunofluorescence microscopy in vertical sections of frozen samples of human
WHM (a, d, f, and i) 2 hours, (b, e, g, and j) 24 hours, and (c and h) 5 days after wounding demonstrating the localization of (a–e) c-Fos (red) and (f–j) Jun B (red).
40,6-diamidino-2-phenylindole-stained nuclei (blue). (d) Is a higher magnification of (a), (e) of (b), (i) of (f), and (j) of (g). The arrow in (g) denotes the leading edge
of the regenerating epidermis. Bar¼ 50 mm.
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in some models at 2 and 3 days distant from the wound. This
indicates that changes in staining of c-Fos at time points
X18 hours might be due to culture conditions and not due to
wound healing events.
Fos B. Cytoplasmic staining of Fos B was enhanced directly at
the wound margins 2 and 7 hours after wounding (Figure 4f
and i). At 18, 24 hours, 2, and 3 days after wounding,
cytoplasmic staining in the regenerating epidermis was only
faint or absent (Figure 4g and j for 24 hours). Completely
regenerated epidermis exhibited a uniform cytoplasmic
staining. Cells distant from the wound showed the same
staining pattern as cells in normal skin except for 5 days after
wounding, where a slight decrease in staining intensity in all
cells was observed (data not shown). In vivo wound healing 2
and 7 hours after wounding did not show the increase in
cytoplasmic staining at the wound margins (data not shown).
In summary, our results show that AP-1 subunits were
absent in nuclei of keratinocytes at the wound margins after
2 hours. Seven hours after wounding, Jun B, Jun D, and Fos B
were still absent from the wound margins in all models,
whereas c-Jun and c-Fos were negative in one model but
strongly positive in two other models. In in vivo experiments,
all proteins were absent from the wound margins 7 hours after
wounding. Eighteen hours after wounding, Jun B, Jun D, and
Fos B were still negative in the cells of the leading edges
except for one model for Jun D, whereas nuclear staining of
c-Jun and c-Fos was clearly positive. At 24 hours, 2, and 3
days after wounding, nuclei of leading edges were clearly
positive in most models for all nuclear AP-1 subunits. In some
models Jun D and Jun B remained negative (Figure 5).
Comparison of the expression of AP-1 subunits and Cx43 during
early reepithelialization
Two hours after wounding, c-Jun, Jun B, Jun D, and c-Fos
were absent from the nuclei of cells directly located at all
wound margins of in vivo wounds, whereas a faint staining
for Cx43 was detectable, which was less intensive than Cx43
staining behind the wound margins where AP-1 subunits
were still present (Figure 6a, c, e, and g). Seven hours after
wounding, c-Jun, Jun B, Jun D, and c-Fos were absent at the
wound margins and most of the cells were negative for Cx43
(Figure 6b, d, f, and h).
Chronic wounds
c-Jun. In eight out of nine cases, the nuclei of keratinocytes at
the wound margins were more intensely (5/9; (Figure 7a)) or
equally (3/9) stained than nuclei behind the wound margins.
This is comparable to later time points of normal wound
healing (X18 hours). One case exhibited a loss of nuclear
staining at the wound margins. In two out of nine cases
cytoplasmic staining was found in addition to nuclear
staining at the wound margins.
Jun B. Nuclear Jun B staining was increased at the wound
margins compared to cells behind the wound margins in two
out of nine cases and showed uniform staining in four cases
(Figure 7b). A decrease of staining was observed in three
cases, one of them exhibited a complete loss.
Jun D. A decrease in nuclear staining of keratinocytes at the
wound margins was found in six out of nine cases (Figure 7c).
In two of these cases also cells behind the wound margins
showed weaker staining than normal skin. In three out of nine
cases no changes in Jun D staining were found.
c-Fos. An increased nuclear staining at and behind the wound
margins, comparable to later time points of normal wound
healing, was found in four cases. Nuclear c-Fos staining was
uniform in two cases. A slight decrease in nuclear c-Fos
staining was observed in three out of nine cases (Figure 7d).
Cytoplasmic staining increased in three cases.
Fos B. Cytoplasmic Fos B staining did not change at the
wound margins in six out of nine cases (Figure 7e). Two
samples showed a decreased Fos B staining in the upper
spinous layers at and behind the wound margins. Staining
intensity was increased in one case.
DISCUSSION
Here, we show that the expression of AP-1 in normal human
epidermal wound healing is regulated in a biphasic manner.
In the first phase all AP-1 subunits investigated, that is c-Jun,
Jun B, Jun D, c-Fos, and Fos B are absent from the nuclei at
the wound margins/leading edges. This downregulation
coincides with that of the gap junction protein Cx43. Later
on, c-Jun, Jun B, Jun D, and c-Fos reappear in the nuclei of
the leading edges in a time-dependent manner. In non-
healing wounds a more intensive staining of keratinocytes at
the wound margins is often observed.
Recent studies have shown that the subunits of transcrip-
tion factor AP-1 play important roles in the skin, especially in
the course of wound healing (see also introduction). Most of
these studies concentrated on one or two subunits but there is
increasing evidence that the functions of various AP-1
subunits are interconnected. Most defects which were
associated with the loss of c-Jun were abrogated by an
overexpression of Jun B (Weitzman et al., 2000). The
expression of transgenous Jun B was able to prevent death
of Fra-1 knockout mice (Schreiber et al., 2000). Fibroblasts
lacking c-Fos or Fos B proliferate normally, a loss of both
results in decreased proliferation capacity (Brusselbach et al.,
1995; Brown et al., 1998). Inducible epidermal single
knockout of c-Jun and Jun B did not show any characteristic
phenotype, whereas a double knockout resulted in psoriasis-
like skin disease (Zenz et al., 2005). Transfection of c-Jun or
Jun B had no effect on transcription from the Cx43 promoter,
whereas combinations of Jun and Fos family members led to
increases in transcription levels (Mitchell and Lye, 2005).
Therefore, we investigated in parallel three members of
the Jun family (c-Jun, Jun B, and Jun D) as well as two
members of the Fos family (c-Fos and Fos B). The staining
patterns of the AP-1 subunits in normal epidermis were
comparable to that found by Mehic et al. (2005) except for
www.jidonline.org 2457
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c-Jun. C-Jun was found in the nuclei of all layers of the
epidermis with increasing intensity from basal to suprabasal
layers in our study, a staining pattern similar to that found by
Zenz et al. (2005), whereas it was restricted to the lower
stratum spinosum and to stratum granulosum in the paper of
Mehic. We do not have an explanation for this discrepancy
except for the use of different antibodies (TDL31920 which is
directed to amino acids 26–175 of mouse c-Jun (Mehic et al.,
2005) versus SC822 which is directed to amino acids 59–69
of human c-Jun in this study). We were able to reproduce our
results with various skin samples that were both cryo- and
formalin-fixed.
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Figure 5. Intensity of immunofluorescence staining of nuclei at the wound margins/leading edges. Immunofluorescence intensity (0¼negative, 1¼weak,
2¼ intermediate, 3¼ strong) of nuclei at the wound margins/leading edges stained for (a) c-Jun, (b) Jun B, (c) Jun D, and (d) c-Fos 2, 7, 18, 24, 48, 72, and
120 hours after wounding. Mean þ / SEM (n¼ 5 except for 7 hours (n¼ 3) and 24 hours (n¼ 4)). (e and f) Comparison of the means of intensity of the proteins of
(e) the Jun and (f) the Fos-families 2, 7, 18 and 24 hours after wounding. 0 hour¼ normal epidermis. Downregulation is statistically significant (Po0.05) for c-Jun
and c-Fos at 2 hours, for Jun D at 2 and 7 hours, and for Jun B at 2, 7, and 18 hours. Note the large SEM at the points in time where reinduction of the nuclear AP-
1 subunits occurs as at these time points some of the models are still negative, whereas others are already strongly positive.
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Fetal calf serum is known to influence the expression of
AP-1 subunits (Gangnuss et al., 2004; Mehic et al., 2005). To
exclude that the results observed in our WHM were due to
culture conditions, especially fetal calf serum, we investi-
gated in vivo wounds of two healthy volunteers in parallel. As
the most tremendous changes in staining patterns took place
2 and 7 hours after wounding, these time points were chosen
for our in vivo experiments. The changes of the nuclear
staining patterns of AP-1 subunits were identical in in vivo
and WHM experiments. However, the increase of cytoplas-
mic staining at the wound margins often observed in WHM
was absent in in vivo wounds and therefore seems to be a
result of culture conditions. Moreover, we investigated areas
in our WHM that were distant from the wound margins.
These areas should not be influenced from wound healing
and should show the same staining patterns for AP-1 subunits
as normal epidermis. This was true for c-Jun, Jun B, and Jun D
at all time points investigated. For Fos B there was a slight
decrease in cytoplasmic staining 5 days after wounding. For
c-Fos there was an alteration of staining intensity at
X18 hours of reepithelialization. Therefore, results for c-Fos
at time points X18 hours and Fos B at 5 days have to be
interpreted carefully, whereas we can exclude that the results
described here for nuclear staining of c-Jun, Jun B, and Jun D
at all time points are due to cell culture effects.
In the course of reepithelialization, we observed a
downregulation of nuclear staining of all AP-1 subunits
normally localized in the nuclei 2 hours after wounding.
Whereas for c-Jun and c-Fos nuclear staining was restored in
some models at 7 hours, and in all models at 18 hours, the
downregulation persisted for Jun B in all, for Jun D in most
models for 18 hours, in some models for Jun B even up to 3
days. A downregulation of Jun B on protein level and the
transcripts of c-Fos and c-Jun was also found in psoriasis
(Basset-Seguin et al., 1991; Zenz et al., 2005). Inducible
double knockout mice for Jun B and c-Jun exhibited a
psoriasis-like skin phenotype (Zenz et al., 2005). An early
molecular event in the development of this phenotype was
the increase in expression of S100A8 and S100A9, chemo-
tactic proteins important for the attraction of neutrophils and
macrophages. Therefore, the downregulation of AP-1 sub-
units, especially Jun B and c-Jun, found in our study, might be
important for the regular progress of inflammatory phase of
wound healing including the attraction of neutrophils and
macrophages. This hypothesis is further supported by the
findings that a downregulation of c-Fos and c-Jun was also
found in other inflammatory hyperproliferative skin diseases
(Basset-Seguin et al., 1991) and that Jun B knockout mice
show a prolonged inflammatory phase (Florin et al., 2006).
Cx43 has been described as a downstream target of AP-1
(Echetebu et al., 1999), its expression is increased by elevated
levels of Jun and Fos proteins, for example in myometrial
cells (Mitchell and Lye, 2005). In normal reepithelialization,
Cx43 is downregulated as soon as 5 hours after wounding
(Brandner et al., 2004). This event seems to be important for
wound healing as both, Cx43-deficient mice and mice that
were treated with Cx43 antisense gel demonstrated acceler-
ated wound healing (Kretz et al., 2003; Qiu et al., 2003). We
show that the downregulation of AP-1 subunits is preceding
the loss of Cx43 at the beginning of wound healing.
Therefore, downregulation of AP-1 subunits might lead to
the downregulation of Cx43. Thus, in addition to attracting
inflammatory cells, AP-1 regulation might also influence gap
junctional intercellular communication in the course of
reepithelialization.
In skin explants of fetal rat skin, expression of c-Fos and c-
Jun was induced as soon as 0.5 hours after wounding and
persisted for up to 6 hours for c-Fos and more than 24 hours
for c-Jun (Gangnuss et al., 2004). In hind limbs of embryonic
rats c-Fos protein was detectable 15 minutes after injury
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Figure 6. Comparison of the localization of AP-1 subunits and Cx43 in early
stages of reepithelialization. Immunofluorescence localization of (a and b) c-
Jun (red), (c and d) Jun B (red), (e and f) Jun D (red), (g and h) c-Fos (red), and
(a–h) Cx43 (green) in frozen sections of human in vivo wound samples (a, c, e,
and g) 2 hours and (b, d, f, and h) 7 hours after wounding (blue) nuclei. Arrows
indicate individual AP-1-negative nuclei, brackets indicate areas with AP-1-
negative nuclei. Bar¼ 50 mm.
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(Martin and Nobes, 1992). The differences between these
reports and our results, that is an induction of AP-1 subunits
soon after wounding in these reports and a loss of AP-1
subunits in our experiments at early time points might be due
to different species (the expression pattern of AP-1 subunits in
rodent skin is different to that in human skin (Rutberg et al.,
1996; Angel et al., 2001; Mehic et al., 2005) and differences
between fetal and adult skin.
In the course of normal reepithelialization, nuclear
staining of c-Jun, c-Fos, Jun B, and Jun D reappear 7 hours
to 3 days after wounding in the nuclei of the keratinocytes at
the wound margins and at the leading edges of the
regenerating epidermis. Often cells of the leading edge were
more intensely stained than other cells. This subsequent
upregulation of nuclear AP-1 subunits seems to be important
for wound healing as c-Jun knockout mice show significantly
delayed wound healing between 9 and 12 days after
wounding. Four days after wounding, an absence of invasion
of the leading edge into the fibrin clot was observed (Li et al.,
2003). Mice lacking Jun B in the skin show delayed wound
healing, enhanced epidermal hyperproliferation, disturbed
differentiation, and prolonged inflammation after wounding
(Florin et al., 2006). Gallucci et al. (2000) showed an
induction of AP-1 16 hours after wounding and demonstrated
that this was not the case in interleukin-6 knockout mice
which, again, exhibited delayed wound healing.
In chronic wounds expression patterns of AP-1 subunits at
the wound margins often resemble those of the leading edges/
regenerating epidermis at later time points of normal wound
healing (X24 hours), for example a more intense staining of
c-Jun and c-Fos. This confirms results found by Ouahes et al.
(1998), who observed an increased level of c-Fos mRNA in
the basal cell layer of chronic wounds compared to normal
skin. It is not clear, whether AP-1 downregulation, which is
observed at the beginning of normal reepithelialization has
occurred in these wounds after injury and they subsequently
progressed to a chronic stage, or whether the downregulation
was absent and this is part of pathogenesis. Anyway, for a
restart of normal wound healing it might be helpful to
downregulate AP-1 subunits in chronic wounds. Interestingly,
Cx43 is also present at the wound margins of chronic wounds
(Brandner et al., 2004), again alluding for a possible
interconnection of these proteins.
In summary, we observed a biphasic regulation of AP-1
subunits in the course of human reepithelialization. Both,
downregulation of AP-1 subunits at early time points
and induction of AP-1 subunits at later time points seem to
be important for regular reepithelialization. The detailed
knowledge of AP-1 regulation in the course of all wound-
healing phases is essential to understand the mechanisms of
wound healing. It might help to provide further tools for the
treatment of chronic wounds, for example by developing
specific inhibitors of AP-1 subunits that can be applied
topically.
MATERIALS AND METHODS
Tissues, antibodies, and nuclear dyes
Normal human skin (n¼ 20; 11 female, 9 male, 18–72 years, various
localizations excluding face, scalp, palmae, and plantae) was
obtained during the routine clinical removal of tumors and
epidermal cysts; the skin used for investigation was localized at
least 2 cm from the respective lesion. The permission for usage was
given by the Local Medical Ethics Committee (060900). Samples
from non-healing wounds were obtained from the borders of chronic
leg ulcers that had existed for at least several weeks without healing.
The samples were not used before diagnostic procedures were
completed and all patients (four women, five men; 43–83 years) gave
their informed consent. Ulcers’ aetiology was either mixed vascular
disease (venous and arterial of various degrees; seven individuals), or
diabetes (two individuals). The usage of the samples was approved
by the Local Medical Ethics Committee (OB 15/04). The tissues were
fixed in formalin and embedded in paraffin. Experiments were
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Figure 7. Localization of AP-1 subunits at the wound margins of chronic wounds. Immunofluorescence microscopy of (a, epifluorescence; d, phase contrast) c-
Jun , (b and e) Jun B, (c and f) Jun D, (g and i) c-Fos, and (h and j) Fos B. The white lines mark the boundaries of epidermal tissue. Bar¼ 50 mm.
2460 Journal of Investigative Dermatology (2007), Volume 127
A Neub et al.
AP-1 in Epidermal Wound Healing
carried out with the institutional approval and in adherence to the
Declaration of Helsinki Principles.
Rabbit polyclonal antibodies raised against Jun B (210; sc73), c-
Fos (H-125; sc7202), and Fos B (102; sc48), mouse mAb raised
against p-c-Jun (KM-1; sc822) and goat polyclonal antibodies raised
against Jun D (329; sc74) as well as JunB (210-P), FosB (102-P), and
JunD (329-P) blocking peptides were obtained from Santa Cruz
Biotechnologies (Santa Cruz, CA). Rabbit polyclonal antibodies
directed to Cx43 (71–0700) were purchased from Zymed Labora-
tories (San Francisco, CA), mAbs (C13720) from BD Transduction
Laboratories (San Diego, CA). Secondary Cy3-coupled antibodies
were purchased from Dianova (Hamburg, Germany), secondary
Alexa 488- and Alexa 594-coupled antibodies from Invitrogen
(Karlsruhe, Germany). For nuclear staining, 40,6-diamidino-2-phe-
nylindole (Boehringer Mannheim, Mannheim, Germany) was used.
Human WHMs
For investigation of epidermal wound healing, the human skin organ
culture model was used as described (Moll et al., 1998, 1999;
Brandner et al., 2002, 2004). Immediately after excision of the
human skin, biopsies (+ 6 mm) were taken including both
epidermis and dermis. Subsequently, for induction of a central
wound, a central biopsy (+ 3 mm) was taken from the respective
sample removing both, the epidermis and upper dermis. The
biopsies were placed dermis down on gauze in culture dishes filled
with appropriate medium that was in contact with the dermis only
(‘‘air–liquid interphase’’). The resultant ‘‘WHMs’’ were incubated
with 10% CO2 at 371C for 2, 7, 18, 24 hours, 2, 3, and 5 days. The
samples were snap-frozen in isopentane precooled with liquid
nitrogen and stored at 801C. For examples of WHM at different
time points see Figure S1.
In vivo wound-healing experiments
For in vivo investigation of reepithelialization, two biopsies with a
diameter of 3 mm were taken from the lower back of two volunteers
(women, 34 and 51 years). After 2 and 7 hours biopsies with a
diameter of 6 mm were taken in such a way that the 3 mm biopsies
were exactly in the center. The biopsies were shock-frozen as
described above. The study was approved by the Local Ethics
Committee (OB-051/06).
Immunofluorescence microscopy
Immunofluorescence staining of frozen tissues and paraffin sections
were performed as described (Brandner et al., 2004). Unspecific-
binding sites of the frozen tissues were blocked at room temperature
for 10 minutes using 2% normal goat serum for Fos B and 2% normal
goat serum plus 0.1% Triton for c-Jun, and c-Fos. Paraffin sections
that were stained with antibodies specific for Jun D were trypsinated
(0.001% trypsin for 10 minutes at 371C) before incubation with
antibodies. For c-Jun, Jun B, and Jun D-staining paraffin sections
were further incubated with 0.1% Triton X 100 for 10 minutes.
Unspecific binding sites of paraffin sections were blocked with 2%
dry milk powder and 2% normal goat serum for all antibodies except
Jun D, which was blocked with 2% dry milk powder and 2% normal
donkey serum. Primary antibodies were diluted as follows: frozen
sections: c-Jun 1:300, Jun B 1:20, Jun D 1:200, c-Fos 1:100, Fos B
1:300, Cx43 (mouse) 1:150, Cx43 (rabbit) 1:250; paraffin sections: c-
Jun 1:100, Jun B 1:100, Jun D 1:100, c-Fos 1:150, Fos B 1:50 (all in
phosphate-buffered saline). Cy3-, Alexa 488- and Alexa 594-
coupled secondary antibodies were diluted 1:500 in phosphate-
buffered saline. For negative controls isotype-matched antibodies
were used. For Jun B, Jun D, and Fos B immunofluorescence
specificity was in addition determined by preabsorbing primary
antibodies with their respective blocking peptides. As described by
Rusovici and Lavoie (2003), primary antibodies were preabsorbed
using a fivefold excess concentration of blocking peptide for
1.5 hours at room temperature before addition to the sections.
Nuclei were stained by incubation with 40,6-diamidino-2-phenylin-
dole (1:5000 in phosphate-buffered saline).
An Axiophot II microscope (Zeiss, Goettingen, Germany) and
Openlab 2.0.4 software (Improvision, Coventry, UK) were utilized to
visualize and evaluate the stained sections.
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SUPPLEMENTARY MATERIAL
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